Multiple myeloma in 2020: state of the art

Panminerva Med. 2020 Dec;62(4):191-192. doi: 10.23736/S0031-0808.20.04159-2. Epub 2020 Sep 22.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Congresses as Topic
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Multiple Myeloma / immunology
  • Multiple Myeloma / metabolism
  • Multiple Myeloma / pathology
  • Multiple Myeloma / therapy*
  • Stem Cell Transplantation* / adverse effects
  • Treatment Outcome

Substances

  • Antineoplastic Agents